What Long COVID investigators can learn from four decades of ME/CFS research.
Jason, Leonard A, Natelson, Benjamin H, Bonilla, Hector et al. · Brain behavior and immunity integrative · 2023 · DOI
Quick Summary
This article reviews 40 years of research on ME/CFS to provide guidance for scientists studying Long COVID. The authors explain how ME/CFS researchers have developed reliable ways to diagnose the illness, define symptoms, and measure severity—lessons that can help Long COVID researchers do the same. By learning from ME/CFS experience, Long COVID researchers may be able to diagnose patients earlier, understand what causes the illness, and find treatments that actually work.
Why It Matters
For ME/CFS patients, this article is important because it validates four decades of work establishing rigorous diagnostic standards and emphasizes that ME/CFS and Long COVID likely share similar research needs. For researchers, this paper provides a roadmap for developing more consistent and reliable ways to diagnose and study Long COVID, which could lead to faster discovery of treatments and better patient outcomes.
Observed Findings
ME/CFS research has successfully developed reliable classification systems and diagnostic instruments over 40 years.
Psychometric validation—including reliability and validity testing—has been a substantial focus in ME/CFS research.
Key methodological challenges include specifying symptom thresholds, identifying disease subtypes, and defining exclusionary conditions.
Long COVID researchers face similar definitional and measurement challenges that ME/CFS researchers have addressed.
Structured, evidence-based approaches to case definition can improve early diagnosis and treatment identification.
Inferred Conclusions
Long COVID researchers should adopt rigorous psychometric methods and classification frameworks already established in the ME/CFS field.
Better case definitions for Long COVID will require careful specification of symptoms, severity thresholds, and exclusionary criteria similar to those developed for ME/CFS.
Applying ME/CFS methodological lessons to Long COVID research could accelerate understanding of pathophysiology and identification of effective treatments.
Systematic diagnostic approaches will improve the quality and comparability of Long COVID research across studies.
Remaining Questions
What This Study Does Not Prove
This article does not prove that ME/CFS and Long COVID are identical diseases or that all ME/CFS treatments will work for Long COVID patients. It is a review of methodological approaches rather than a study providing new clinical or biological evidence. The recommendations offered are based on expert synthesis rather than new experimental or observational data.